Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe.

Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...